Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin
- 27 September 2017
- journal article
- letter
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 74 (1), 139-140
- https://doi.org/10.1007/s00228-017-2339-7
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- A systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiencyEuropean Journal of Clinical Pharmacology, 2015
- Anticoagulation: Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical SettingsAnnals of Pharmacotherapy, 2009
- Bridging of oral anticoagulation with low-molecular-weight heparin: Experience in 373 patients with renal insufficiency undergoing invasive proceduresThrombosis and Haemostasis, 2009
- Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal InsufficiencyAnnals of Internal Medicine, 2006